FDA sends warning letter after Chinese supplier breaks GLP-1 import restrictions
Thursday, May 21 – While the manufacturer is on the list of authorized GLP-1 importers, FDA inspectors found the company relabeled APIs from another site in a potential attempt to “circumvent safeguards.”
How GLP-1s Like Ozempic Turn Down ‘Food Noise’ to Help You Lose Weight
Thursday, May 21 – GLP-1 drugs may help reduce food cravings, leading to healthier eating habits that contribute to weight loss. Image Credit: Juan Moyano/Stocksy
A recent study found that using GLP-1 drugs, such as Ozempic and Mounjaro, can help reduce food cravings.
The researchers found that GLP-1 medications can reduce “food noise” better than behavioral therapy alone.
Food noise refers to persistent and intrusive thoughts about food that make healthy eating habits difficult.
Oral GLP-1s without fasting or reduced efficacy: Delivery approach protects peptide-based drugs from stomach acid
Wednesday, May 20 – Biomedical engineers at Duke University have developed a new approach to delivering GLP-1 medications orally that does not require fasting and maintains their efficacy. The technique could also be useful for any pharmaceutical based on peptides such as insulin or treatments for irritable bowel syndrome, HIV and osteoporosis.
GLP-1s vs Bariatric Surgery; Obesity Trends Reversing; Creatine for Menopause?
Wednesday, May 20 – (MedPage Today) — GLP-1 medication use increased by 140.4% from 2022 to 2024 while metabolic bariatric surgery utilization declined by 34.1%, national insurance data indicated. (JAMA Surgery)
Generic forms of semaglutide (Ozempic, Wegovy) aren…
GLP-1 Receptor Agonists Tied to Better Outcomes in Certain Patients With Breast Cancer
TUESDAY, May 19, 2026 — Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with better outcomes among patients with breast cancer and obesity or type 2 diabetes, according to a study published online May 11 in JAMA Network…
Vincentage’s oral GLP-1 meets phase III obesity endpoints
Wednesday, May 20 – Vincentage Pharma Co. Ltd.’s once-daily oral small-molecule GLP-1 receptor agonist, VCT-220, met the primary endpoints in a pivotal phase III trial in overweight or obese patients in China. Based on the top-line data, the Chengdu, China-based company plans to submit an NDA for chronic weight management to China’s National Medical Products Administration.
Wegovy: Semaglutide Reduces Migraine Severity, Especially in Women
Wednesday, May 20 – A new study found that women using semaglutide had a reduction in their use of triptans, a drug commonly prescribed for migraine. Victor Bordera/Stocksy
A study has found that treatment with semaglutide led to reduced triptan usage in women.
However, no significant effect was observed in men with overweight or obesity.
Experts say reductions in inflammation or intracranial pressure could play a role.
What is ‘Ozempic Personality’? How GLP-1s Can Affect Mood
Wednesday, May 20 – GLP-1s like Wegovy and Zepbound are transforming the weight loss landscape but along with physical changes, a number of patients are reporting a loss in joy or pleasure. The reports of the unexpected side effect, which some dub “Ozempic personality,” are all anecdotal but weight loss drug patients across social media are opening up in growing numbers. NBC’s Anne Thompson reports for TODAY.
People who lost the most weight on Ozempic saw huge health benefits
Wednesday, May 20 – People who lost significant weight while taking Ozempic, Wegovy, Mounjaro, or Saxenda had sharply lower risks of major obesity-related health problems, including sleep apnea and kidney disease. Those who gained weight instead faced higher risks — especially for heart failure — even though many patients discontinued the medications within a year.
GLP-1 Drugs Linked to Significant Boost in Testosterone Levels for Men
Wednesday, May 20 – (MedPage Today) — WASHINGTON — Men treated with GLP-1 receptor agonists had significant increases in testosterone levels, according to findings from a retrospective analysis.
Among men who received semaglutide (Ozempic, Wegovy) or tirzepatide…